Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity.
ACS Med Chem Lett
; 2(1): 43-7, 2011 Jan 13.
Article
in En
| MEDLINE
| ID: mdl-24900253
Full text:
1
Database:
MEDLINE
Language:
En
Year:
2011
Type:
Article